270 results on '"Rabizadeh S"'
Search Results
2. Dissecting allele architecture of early onset IBD using high-density genotyping
3. P181 infliximab exposure during induction associate with time to remission and disease control of inflammatory bowel disease
4. SO-28 A randomized phase II trial of mFOLFOX6-based standard of care alone or in combination with Ad-CEA vaccine plus avelumab in patients with previously untreated metastatic colorectal cancer
5. A30 Tumor-Infiltrating Lymphocytes (TILs) Found Elevated in Lung Adenocarcinomas (LUAD) Using Automated Digital Pathology Masks Derived from Deep-Learning Models
6. Comparative analysis of tumour mutational burden (TMB) prediction methods and its association with determinants of the tumour immune microenvironment of urothelial bladder cancer (UBC)
7. P1.01-68 Monitoring Clinical Responses Measuring PD-L1 in cfRNA in Plasma of Non-Small Cell Lung Cancer Patients Undergoing Systemic Therapy
8. A phase I study of Ad5 PSA/MUC-1/brachyury vaccine in patients with metastatic castration resistant prostate cancer (mCRPC)
9. In-situ diversification of immunity following vaccination targeting tumor neoepitopes; an integral component of combinatorial immunotherapy
10. Abstract P2-09-04: Identification of a neoantigen targeted by tumor-infiltrating lymphocytes in a patient with Her2+ breast cancer
11. TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes
12. MA19.06 Blood Based Biomarkers: RNA, KRAS and PD-L1 Strongly Matching with Tissue and Showing Correlation with Clinical Responses In NSCLC Patient’s
13. TILGen: Eine Studie zur Untersuchung immunonkologischer Marker für die Behandlung des Mammakarzinoms – Erste Ergebnisse zum Einfluss Tumor-infiltrierender Lymphozyten
14. PS5 New Biomarkers to Follow Therapy Response in Plasma of NSCLC Patients
15. Abstract P1-07-20: Developing prognostic indicators of poor outcomes in PRAEGNANT metastatic breast cancer cohort
16. Abstract P2-02-16: Use of cell-free circulating RNA and expression of PD-L1 and HER2 in plasma to monitor and predict clinical response in metastatic breast cancer patients
17. Systematic identification of (personalized) tumor-specific neoantigens through whole genome & whole transcriptomic analyses of 158 Asian colorectal cancers
18. P2.01-056 Use of Cell-Free Circulating RNA (cfRNA) Expression of PD-L1 and ERCC1 in Plasma to Monitor Response to Therapy in NSCLC
19. OA 18.04 Whole Genome Tumor-Normal Sequencing Reveals Potential False Positives Versus Standard CGP Sequencing in Patients with NSCLC
20. Abstract P2-04-26: Identifying patient-specific neoepitopes for cell-based and vaccine immunotherapy across breast cancer classifications reveals rarely shared recurrent neoepitopes
21. Abstract P2-04-10: High-affinity activated natural killer (haNK) cells augment trastuzumab efficacy in a mouse model of HER2-positive human metastatic breast cancer
22. 936P - Comparative analysis of tumour mutational burden (TMB) prediction methods and its association with determinants of the tumour immune microenvironment of urothelial bladder cancer (UBC)
23. 874P - A phase I study of Ad5 PSA/MUC-1/brachyury vaccine in patients with metastatic castration resistant prostate cancer (mCRPC)
24. 358P - Complete responses in patients with second-line or greater metastatic triple negative breast cancer (TNBC) following first-in-human immunotherapy combining NK and T cell activation with off-the-shelf high-affinity CD16 NK cell line (haNK)
25. Identifying patient-specific neoepitopes for cell-based and vaccine immunotherapy within The Cancer Genome Atlas reveals rarely shared recurrent neoepitopes
26. P-038 MET activation via exon 14 skipping mutations (METex14del): gastrointestinal prevalence and sensitivity to MET inhibitor AMG337
27. Multiomic approach to determine prognosis for patients with HER2-positive breast cancer
28. Abstract P2-11-12: Novel protocol combining metronomic nant-paclitaxel with HER2-targeted natural killer cells (innate immunotherapy) for HER2-positive metastatic breast cancer
29. Abstract P6-05-08: Integrating whole exome sequencing data with RNAseq and quantitative proteomics to better inform clinical treatment decisions in patients with metastatic triple negative breast cancer
30. Abstract P6-04-14: Integrating whole genome sequencing data with RNAseq, pathway analysis, and quantitative proteomics to determine prognosis after standard adjuvant treatment with trastuzumab and chemotherapy in primary breast cancer patients
31. Induction of Persistent Colitis by a Human Commensal, Enterotoxigenic Bacteroides fragilis, in Wild-Type C57BL/6 Mice
32. 550O - Systematic identification of (personalized) tumor-specific neoantigens through whole genome & whole transcriptomic analyses of 158 Asian colorectal cancers
33. Label-free high-throughput imaging flow cytometry
34. 319 - Identifying patient-specific neoepitopes for cell-based and vaccine immunotherapy within The Cancer Genome Atlas reveals rarely shared recurrent neoepitopes
35. Hyper-dimensional analysis for label-free high-throughput imaging flow cytometry
36. Edge assay: kinetic analysis of reagents affecting cell clumping
37. Neurotrophin dependence mediated by p75NTR: contrast between rescue by BDNF and NGF
38. Label-free high-throughput imaging flow cytometry.
39. Stat3 activation in enterotoxigenic Bacteroides fragilis induced intestinal inflammation
40. Receptors that mediate cellular dependence
41. A cytoplasmic peptide of the neurotrophin receptor p75NTR: induction of apoptosis and NMR determined helical conformation
42. Cell death mechanisms in ALS
43. Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: studies in yeast and neural cells.
44. Expression of the low-affinity nerve growth factor receptor enhances beta-amyloid peptide toxicity.
45. Expression of the Baculovirusp35Gene Inhibits Mammalian Neural Cell Death
46. Selective vulnerability in Alzheimer's disease: amyloid precursor protein and p75(NTR) interaction.
47. Label-free high-throughput imaging flow cytometry
48. Neurotrophin dependence mediated by p75NTR: contrast between rescue by BDNF and NGF.
49. Expression of the Baculovirus p35 Gene Inhibits Mammalian Neural Cell Death.
50. The copper transport protein Atox1 promotes neuronal survival.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.